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a  b  s  t  r  a  c  t
INTRODUCTION:  Clear  cell  gallbladder  carcinoma  accounts  for  less  than  1% of all gallbladder  malignancies
and  demonstrates  its  unique  histopathological  characteristics  in  patients  with  no  prior  medical  illness
or  familial  predisposition.
PRESENTATION  OF  CASE:  Here  we  present  a case  of  a 56-year-old  female,  with  no  prior medical  conditions
presented  with  a 2-month  history  of  upper  abdominal  pain.  Routine  hematological  and  biochemical  tests
were  unremarkable.  An  abdominal  ultrasound  revealed  the  presence  of a gallbladder  calculi,  and  a  fundic
mass while  magnetic  resonance  cholangiopancreatography  revealed  a  8.0  cm × 3.5  cm  gallbladder  mass.
Computed  tomography  imaging  excluded  any distant  haematogenous  metastases.  An  open  cholecystec-
tomy  with  lymphadenectomy  was proceeded  by  staging  laparoscopy.  Upon  pathologic  investigation,  the
morphologic  and  immunophenotypic  features  supported  a  diagnosis  of  clear  cell  variant  of  gallbladder
carcinoma.
DISCUSSION:  Pathological  prognostications  for primary  clear  cell  gall bladder  carcinomas  are  not  well
deﬁned  due  to the  rarity  of  cases  and  possible  misidentiﬁcation  as  secondary  metastases.  Foci  of  ade-
nocarcinoma  within  the  tumor  along  with  immunohistochemical  staining  probes  can  be  informative  in
consideration  of differential  diagnosis.
CONCLUSION:  In these  cases,  clinical  case  management  should  be personalized  for increased  survival  with
the possible  incorporation  of  next  generation  sequencing  approaches  to  guide  therapeutic  algorithms.  We
discuss  this  exceedingly  rare  case  of  the clear  cell variant  of gallbladder  carcinoma  in detail,  highlighting
some  of  the diagnostic,  and clinical  challenges.
©  2017  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Gallbladder carcinoma is a rather uncommon malignancy with
signiﬁcant geographical variation with respect to incidence and
prevalence. Regions and communities with the highest prevalence
include Korea, Japan, Ecuador, Chile, Alaska and the American
Indians [1]. Incidence ranges from 8 to 12 cases per 100 000 in
males and up to 27.3 cases per 100 000 in females in those peak
indigenous populations, with lower incidences (1.5 cases per 100
000) among other populations [2]. It is usually detected at an
advanced stage mainly due to the ambiguity of its clinical pre-
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sentation, its aggressive biology and its anatomic proximity to the
liver [3]. Risk factors associated with the increased pathogenesis of
gallbladder cancer include infestation, porcelain gallbladder, gall-
bladder polyps, primary sclerosing cholangitis, chronic infection
(e.g. salmonella typhi), congenital malformations and obesity. The
metaplasia-dysplasia-carcinoma sequence may  frame the carcino-
genesis pathway in gallbladder cancer.
The clear cell adenocarcinoma variant of gallbladder carcinoma
is exceedingly rare with less known about its recurrence and overall
survival. An extensive literature search identiﬁed eight case reports
of clear cell gallbladder carcinoma globally in the past seventy
years. To the best of our knowledge, this is the ﬁrst reported case in
the Community of Latin American and Caribbean States. This case
report was  prepared according to the Surgical CAse Report (SCARE)
Guidelines [4] which provides a framework for accuracy in surgical
case reports.
http://dx.doi.org/10.1016/j.ijscr.2017.01.020
2210-2612/© 2017 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. T1 magnetic resonance image of gallbladder neoplasm (at arrowhead).
Fig. 2. Specimen image demonstrating gross morphology of the neoplasm. Surgical
clips noted at the cystic duct margin.
2. Case report
A 56-year-old female with no prior medical conditions pre-
sented to the Eric Williams Medical Sciences Complex, Trinidad
and Tobago with a 2-month history of upper abdominal pain. Rou-
tine hematological and biochemical tests including complete blood
count, renal function tests and liver function tests were unremark-
able. The patient had no history of weight loss, lymphadenopathy,
fever, malaise, bone pain or respiratory issues, nor any neurological
implications suggestive of metastatic or paraneoplastic manifesta-
tions.
An abdominal ultrasound revealed the presence of a gallblad-
der calculi, and a fundic mass which was further investigated with
magnetic resonance cholangiopancreatography (MRCP) and com-
puted tomography (CT) imaging for determination of metastatic
involvement (Fig. 1). MRCP imaging revealed an 8.0 cm × 3.5 cm pri-
mary gallbladder neoplasm without any contiguous involvement
of the liver bed, as well as a few gallstones, the largest of which
measured 1.3 cm.  CT imaging excluded any distant haematogenous
metastases.
Diagnosis and management were discussed with the patient.
The surgical intervention including open cholecystectomy with
lymphadenectomy was proceeded by staging laparoscopy. The
tumor was removed without any complications (Fig. 2). Occult
peritoneal disease and malignancy at the resection margin were
ruled out by the adjunct of frozen sectioning of the cystic duct
margin. At the time of manuscript preparation, the patient was  on
Capecitabine (Xeloda, Roche) and recuperating well.
Histological assessment revealed clear cell carcinoma of the
gallbladder within the fundus and body with the tumor invad-
ing the muscularis but not through the perimuscular connective
tissue. All margins were surgically safe and lymph nodes from sta-
tions 8A and 12B were negative for metastatic tumor. Additionally,
lymphovascular invasion was  absent. Her staging based on Amer-
ican Joint Committee on Cancer (AJCC) guidelines was pT1b pN0
M0;  stage 1 disease. Immmunohistochemical evaluation veriﬁed
that the tumor arose from the mucosal surface of the gallblad-
der thus ruling out any renal background (Fig. 3A). The tumor
cells were characterized by clear cytoplasm, well-deﬁned cytoplas-
mic  borders and hyperchromatic nuclei (Fig. 3B). Additionally, the
tumor cells were positive for cytokeratin-7 (CK-7) and negative
for cytokeratin-20 (CK-20) and paired box gene 8 (PAX8) thereby
eliminating the possibility of metastatic clear cell renal carcinoma
(Fig. 3C, D).
3. Discussion
Gallbladder cancer is the most common and aggressive bil-
iary tract malignancy with the shortest median survival time [5].
Screening efforts are limited due to the paucity of symptoms as well
as the lack of a cost-effective focus mechanism for early stage detec-
tion. The high rates of local recurrence and micro-metastases even
for those considered surgically curable, renders clinical manage-
ment challenging. Pathological prognostications of primary clear
cell gall bladder carcinomas are not well established due to the
rarity of cases as well as possible misidentiﬁcation as secondary
metastases; for example those of renal origin [6,7]. Foci of adeno-
carcinoma may  be found within the tumor and can be informative
in distinguishing primary from metastatic clear cell neoplasms
along with PAX immunohistochemical staining probes [7].
Risk factors include cholelithiasis which is found in associa-
tion with 80–90% of malignancies. Pure cholesterol stones greater
than 1.5 cm are associated with adenosquamous and squamous cell
carcinomas while increased size of the calculi may  increase the
risk of malignant transformation. Chronic infections by salmonella
sp., helicobacter pylori and clonorchis sp. increase the risk for gall-
bladder cancer and are associated with squamous cell as well
as adenosquamous malignancy. Additionally, primary sclerosing
cholangitis, polyps larger than 1 cm in diameter inside the gall-
bladder, choledochal cysts, typhoid and opisthorchis liver disease,
primary sclerosing cholangitis, porcelain gallbladder, and excessive
consumption of red meat and tobacco are all reported to increase
the risk [3].
With the increasing frequency of laparoscopic cholecystectomy
for benign presentations there has been a concomitant increase in
the incidental ﬁnding of gallbladder neoplasms [8,9]. Fortunately,
this confers an increased overall survival beneﬁt to these patients
as a result of the earlier stage at detection. A retrospective analysis
of gallbladder cancer cases from Johns Hopkins reported an overall
ﬁve year survival of 33% associated with cases discovered inciden-
tally, compared with 15% for those diagnosed preoperatively [8].
For incidentally detected neoplasms it is paramount to preserve
the integrity of the gallbladder, obtain closure of possible breaches
in the wall during dissection and use an “endobag” in retrieval of the
gallbladder, in case there is need for re-operation [10]. This has been
indicated for pT2 tumors but there is still controversy with respect
to pT1b tumors, such as this case [11,12]. Considering her rare his-
tological subtype, age, favorable R0 resection, satisfactory recovery,
the absence of metastatic lymphadenopathy, perineural and lym-
phovascular invasion we  decided that extensive re-operation was
not necessary.
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Fig. 3. (A–D) Clear cell adenocarcinoma of gallbladder. A. Lower magniﬁcation (H&E, 20x) shows that the lesion grows as a predominantly polypoid mass arising from the
mucosal surface of the gallbladder. B. Higher magniﬁcation (H&E, 200x) highlights tumor cells with clear cytoplasm, well-deﬁned cytoplasmic borders and hyperchromatic
nuclei. C. By immunohistochemistry, the tumor cells are positive for CK7. D. However, they are negative for PAX8, thus ruling out the possibility of metastatic clear cell renal
carcinoma.
Next generation sequencing somatic mutation proﬁling of gall
bladder tumors has implicated several genes with therapeu-
tic implications [13,14]. These include the oncogenes V-Ki-ras2
Kirsten rat sarcoma viral oncogene homolog (KRAS) and epidermal
growth factor receptor (EGFR). These genes are active in pathways
that provide the stimuli for hyperplasia leading to carcinoma in
patients with anomalous pancreato-biliary anomalies, as well as
inducing neoplastic foci in gallbladder polyps. The phosphatidyl-
inositol 3 kinase oncogene pathway and tumor protein p53 (TP53)
have been implicated in the onset of chronic inﬂammation related
to cholelithiasis [3]. Trials have demonstrated that survival bene-
ﬁt can be achieved with targeted agents such as erlotinib (Tarceva,
Astellas Pharma Inc.), in combination with standard chemother-
apeutic regimens as well as cetuximab (Erbitux, Bristol-Myers
Squibb), when compared with chemotherapy alone [14].
4. Conclusion
Among the many histopathogical subtypes of gallbladder neo-
plasm, clear cell carcinoma is an exceedingly rare variant relative to
adenocarcinoma of the gallbladder. Clinical decision making should
be personalized to improve patient outcomes and survival. In devel-
oping countries, management of these cases would beneﬁt from
an electronic health record system and a digitized cancer registry.
This will allow for data capture and analysis as well as the seamless
integration of a patient’s pathology, clinical algorithm, response,
and survival into a national precision medicine framework. Given
the rarity of clear cell carcinoma of the gallbladder, this case report
will add a needed perspective to clinicians managing similar cases.
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